| P2093 | author name string | Kevin Camphausen | |
| | Roger Packer | |
| | Pamela L Wolters | |
| | Katherine Warren | |
| | Ryan Hanson | |
| | Joanna Shih | |
| | Robyn Bent | |
| | Alisa Prager | |
| P2860 | cites work | Interferons and their actions | Q28305734 |
| | Diffuse brainstem glioma in children: critical review of clinical trials | Q31033307 |
| | Pediatric brain stem gliomas: a review | Q32127884 |
| | Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas | Q33825938 |
| | Role of type 1 IFNs in antiglioma immunosurveillance--using mouse studies to guide examination of novel prognostic markers in humans | Q33959111 |
| | Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers | Q34291120 |
| | Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas | Q34344877 |
| | A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium | Q34722457 |
| | Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group | Q34722864 |
| | Pharmacokinetics of peginterferons | Q35204875 |
| | Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome | Q36821019 |
| | Present role and future potential of type I interferons in adjuvant therapy of high-risk operable melanoma | Q36908038 |
| | Clinical biomarkers of angiogenesis inhibition | Q37139413 |
| | IFN-alpha induces transcription of hypoxia-inducible factor-1alpha to inhibit proliferation of human endothelial cells | Q37331575 |
| | Viral interferon regulatory factors | Q37588733 |
| | Interferons in cell growth and development | Q38201270 |
| | Regulation of cell proliferation and differentiation by interferons | Q38393349 |
| | The interferons: a biological system with therapeutic potential in viral infections | Q40394998 |
| | Role of interferons in the regulation of cell proliferation, differentiation, and development | Q40396710 |
| | Recombinant interferon beta: a phase I-II trial in children with recurrent brain tumors | Q40748749 |
| | Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon | Q43845751 |
| | Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy | Q44748846 |
| | Hyperfractionated radiation therapy for brain-stem glioma: a phase I-II trial. | Q46026846 |
| | Immunobiology of primary intracranial tumors. Part 10: Therapeutic efficacy of interferon in the treatment of recurrent gliomas | Q48443988 |
| | Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis. | Q52952533 |
| | Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule. | Q54073984 |
| | Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant beta-interferon and hyperfractionated radiation therapy: a childrens cancer group phase I/II study. | Q55479622 |
| | Clinical effect of interferon in malignant brain tumours. | Q55488998 |
| | Interferon alpha therapy of haemangiomas in newborns and infants | Q68030165 |
| | Brain-stem tumors in childhood: a prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Childrens Cancer Study Group | Q69728238 |
| | Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas | Q73410052 |
| | Increased incidence of matrix metalloproteinases in urine of cancer patients | Q74427915 |
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pegylated interferon | Q7160835 |
| | diffuse midline glioma | Q25339127 |
| P304 | page(s) | 3607-3613 | |
| P577 | publication date | 2011-11-15 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | A phase 2 study of pegylated interferon α-2b (PEG-Intron(®)) in children with diffuse intrinsic pontine glioma | |
| P478 | volume | 118 | |